Essex Woodlands Management as of June 30, 2019
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 6 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Eyepoint Pharmaceuticals | 39.6 | $69M | 42M | 1.64 | |
| Axogen (AXGN) | 27.7 | $48M | 2.4M | 19.80 | |
| Revance Therapeutics (RVNC) | 25.0 | $43M | 3.3M | 12.97 | |
| Medicinova Com New (MNOV) | 6.5 | $11M | 1.2M | 9.63 | |
| Endologix Com New | 0.8 | $1.4M | 126k | 11.05 | |
| Catalyst Biosciences Com New | 0.3 | $579k | 79k | 7.36 |
